General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.
Centessa Pharmaceuticals ×
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process, with a subsidiary portfolio supported by a centralized infrastructure, asset-centric R&D model and the Centessa management team.
Kalbe Genexine Biologics (“KGBio”) is an Indonesia-based joint venture between Kalbe Farma and Genexine. KGBio focuses on the in-licensing, clinical development, and manufacturing of biological products, especially in the area of immuno-oncology.
Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition.
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
SciNeuro is a clinical-stage biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
Royalty Pharma ×
Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.
Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
Allonnia leverages advanced technologies and biology to engineer breakthrough systems to develop and commercialize new waste remediation and management solutions.
Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and autoimmune disorders.
Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.
Motif FoodWorks ×
Motif FoodWorks is a synthetic biology company that designs and sells ingredients to companies that make plant-based foods and beverages.
PathAI is a leading provider of AI-powered research tools and services for pathology.
Rubicon Research ×
Rubicon is a specialty generics pharmaceutical product-development company engaged in research, development and manufacturing of branded and specialty generic products and OTC products.
Ginkgo Bioworks ×
Ginkgo Bioworks is a synthetic biology company that designs and licenses DNA code for custom designed organisms.